[1] World Health Organization (2013) Global Review of T&CM. In WHO Traditional Medicine Strategy: 2014-2023, WHO Press, 20 Avenue Appia, 1211 Geneva 27, Switzerland, 25-26.
[2] Yang, S.T. and Gao, F. (2007) Pharmacognostical Studies on Coleus forskohlii Briq. Yunnan University of Traditional Chinese Medicine, 30, 8-10.
[3] Xu, L.L. and Kong, L.Y. (2006) Labdane Diterpenoids from Coleus forskohlii (Wild) Briq. Journal of Integrative Plant Biology, 48, 478-481.
http://dx.doi.org/10.1111/j.1744-7909.2006.00177.x
[4] Alasbahi, R.H. and Melzig, M.F. (2012) Forskolin and Derivatives as Tools for Studying the Role of cAMP. Pharmazie, 67, 5-13.
[5] Nie, L.H., Li, X.H., Chen, Z.H., Wang, X.H. and Wang, D.C. (1999) Suppressing Effects of Isoforskolin Administered Topically on Intraocular Pressure in Conscious Rabbits. Chinese Ophthalmology Research, 17, 90-92.
[6] Li, X.H., Nie, L.H., Yang, W.M., Chen, Z.H., Wang, X.H. and Luo, L.H. (2000) Suppressing Effect of Isoforskolin and Forskolin on Ocular Hypertension in Rabbits. Chinese Journal of Ophthalmology, 36, 292-294.
[7] Yang, W.M., Li, X.H., Chen, Z.H., Nie, L.H., Wang, B.L. and Shen, Z.Q. (2001) Adenylate Cyclase Stimulation and Ocular Hypertension Inhibition by Forskolin Analogs. Chinese Ophthalmology Research, 19, 1-4.
[8] Yang, W.M., Li, X.H., Chen, Z.H., Nie, L.H., Li, L. and Lei, W.Y. (2001) Effects of Two Forskolin Analogs on the Elevation of Ocular Pressure in Human. Chinese Journal of Ophthalmology, 19, 556-559.
[9] Ma, G.Y., Chen, Z.H. and Wang, D.C. (1994) The Inhibitory Effects of Isoforskolin on Rat and Guinea Pig Platelet Aggregation in the Whole Blood. Journal of Kunming Medical University, 15, 18-21.
[10] Chen, B.Y., Lei, X.L., Wang, X.H., Chen, Z.H. and Wang, D.C. (1994) The Effects of 1-Acetylforskolin and Isoforskolin on the Hemodynamics in Rats. Journal of Kunming Medical University, 15, 53-55.
[11] Zhao, J.S., Yang, W.M., Yang, Z.B., Li, J.X. and Fu, J.J. (2014) Study on General Pharmacology of Forskolin and Isoforskolin. Journal of Kunming Medical University, 35, 37-40.
[12] Pei, X.N., Qing, C., Chen, G.Z., Xu, Y.L., Jin, Q.D., Ma, L.M. and Yang, W.M. (2008) Effects of Active Ingredients from Coleus forskohlii on Human Neutrophil. Chinese Journal of Emergency Medicine, 17, 1266-1270.
[13] Yang, W.M., Qiang, D.Q., Zhang, M., Ma, L.M., Zhang, Y.H., Qing, C., Xu, Y.L., Zhen, C.L., Liu, J.K. and Chen, Y.H. (2011) Isoforskolin Pretreatment Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Animal Models. International Immunopharmacology, 11, 683-692.
http://dx.doi.org/10.1016/j.intimp.2011.01.011
[14] Wang, Y.Q., Cao, S.J., Yin, J.J., Huang, J.M. and Weng, H.B. (2013) Relaxation Effects of Forskolin Analogues on Isolated Bronchioles in Guinea Pig. Chinese Pharmacological Bulletin, 29, 714-717.
[15] Shan, Y.S., Xu, L.L, Lu, Y., Wang, X.B., Zheng, Q.T., Kong, L.Y. and Niwa, M. (2008) Diterpenes from Coleus forskohlii (Wild) Briq. (Labiatae). Chinese Pharmacological Bulletin, 56, 52-56.
http://dx.doi.org/10.1248/cpb.56.52
[16] Khatun, S., Chatterjee, N.C. and Cakilcioglu, U. (2011) Antioxidant Activity of the Medicinal Plant Coleus forskohlii Briq. African Journal of Biotechnology, 10, 2530-2535.
[17] Paul, M., Radha, A. and Kumar, D.S. (2013) On the High Value Medicinal Plant, Coleus forskohlii Briq. Hygeia Journal for Drugs & Medicines, 5, 69-78.